Beijing Wantai Biological Pharmacy Enterprise's latest marketcap:
As of 06/18/2025, Beijing Wantai Biological Pharmacy Enterprise's market capitalization has reached $11.29 B. According to our data, Beijing Wantai Biological Pharmacy Enterprise is the 1713th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 11.29 B |
| Revenue (ttm) | 263.39 M |
| Net Income (ttm) | -10,049,928.96 |
| Shares Out | 1.27 B |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/03/2024 |
| Earnings Date | 08/22/2025 |
Beijing Wantai Biological Pharmacy Enterprise's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | ¥11.29 B | -9.65% | 1713 |
| 12/31/2024 | ¥89.14 B | -6.44% | 1447 |
| 12/29/2023 | ¥95.28 B | -17% | 1262 |
| 12/30/2022 | ¥114.8 B | -14.62% | 982 |
| 12/31/2021 | ¥134.46 B | 53.87% | 952 |
| 12/31/2020 | ¥87.38 B | 1256 |
Company Profile
About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a leading company specializing in the research, development, production, distribution, and sale of infectious disease diagnostic reagents and vaccines. Operating both in China and internationally, the company plays a crucial role in global healthcare solutions.
Product Offerings
- Chemiluminescence Series – Advanced diagnostic solutions for accurate testing.
- Assembly Line Series – Streamlined diagnostic processes for efficiency.
- Nucleic Acid Series – Cutting-edge molecular diagnostic tools.
- Dry Type Fluorescent Immunoassay – Rapid and reliable diagnostic testing.
- Fully Automatic Blood Type Analyzer & Reagents – Precision in blood typing.
- ELISA Kits – Widely used in disease detection.
- Rapid Diagnosis – Quick and efficient testing solutions.
- Bole Series – Specialized diagnostic products.
- Supporting Reagents – Comprehensive diagnostic support.
Company Background
Founded in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in Beijing, China. With decades of expertise, the company continues to innovate in the field of diagnostics and vaccines, contributing to global health advancements.
Frequently Asked Questions
-
What is Beijing Wantai Biological Pharmacy Enterprise's (SHA-603392) current market cap?As of 06/18/2025, Beijing Wantai Biological Pharmacy Enterprise (including the parent company, if applicable) has an estimated market capitalization of $11.29 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Beijing Wantai Biological Pharmacy Enterprise (SHA-603392) rank globally by market cap?Beijing Wantai Biological Pharmacy Enterprise global market capitalization ranking is approximately 1713 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.